Zobrazeno 1 - 10
of 1 906
pro vyhledávání: '"Rigaud, C."'
Publikováno v:
In Phytochemistry May 2023 209
Autor:
Pereira V; Department of Pediatric Hematology and Oncology, Besançon University Hospital, Besançon, France.; Department of Pediatric and adolescents Oncology, Gustave Roussy cancer Institute, Paris Saclay University, Villejuif, France., Barthoulot M; Department of Methodology and Biostatistics, Oscar Lambret Center, Lille, France., Aladjidi N; Department of Pediatric Oncology and Hematology, Bordeaux University Hospital, Bordeaux, France., Contet A; Department of Pediatric Oncology and Hematology, University Children's Hospital of Nancy, Nancy, France., Dalle JH; Department of Pediatric Hematology and Immunology, Robert Debré Academic Hospital, GHU AP-HP Nord Université Paris Cité, Paris, France., Dourthe MÉ; Department of Pediatric Hematology and Immunology, Robert Debré Academic Hospital, GHU AP-HP Nord Université Paris Cité, Paris, France., Garnier N; Department of Pediatric Hematology and Oncology, Lyon University Hospital, Lyon, France., Bruno B; Department of Pediatric Hematology, Lille University Hospital, Lille, France., Leruste A; Department of Pediatric Oncology, Curie Institute, Paris, France., Pellier I; Department of Pediatric Oncology and Hematology, Angers University Hospital, Angers, France., Simonin M; Department of Pediatric Hematology and Oncology, Trousseau University Hospital, AP-HP, Paris, France., Paillard C; Department of Pediatric Hematology and Oncology, Strasbourg University Hospital, Strasbourg, France., Verschuur A; Department of Pediatric Hematology and Oncology, University Hospital of La Timone, AP-HM, Marseille, France., Ducassou S; Department of Pediatric Hematology and Oncology, Bordeaux University Hospital, Bordeaux, France., Lamant L; Department of Pathology, Cancer University Institute of Toulouse, Toulouse, France., Brugieres L; Department of Pediatric and adolescents Oncology, Gustave Roussy cancer Institute, Paris Saclay University, Villejuif, France., Deley ML; Department of Methodology and Biostatistics, Oscar Lambret Center, Lille, France., Rigaud C; Department of Pediatric and adolescents Oncology, Gustave Roussy cancer Institute, Paris Saclay University, Villejuif, France.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct 21, pp. e31397. Date of Electronic Publication: 2024 Oct 21.
Autor:
Thalhammer J; Institute of Hematology and Pediatric Oncology,Centre Leon Berard,Lyon, France., Jeziorski E; University Hospital of Montpellier, Montpellier, France., Marec-Berard P; Institut d'Hématologie et Oncologie Pédiatrique (IHOPe)., Barkaoui MA; French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France., Pagnier A; Centre Hospitalo-Universitaire de Grenoble, Grenoble Cedex 9, France., Rohrlich PS; CHU Nice, Nice, France., Chevallier A; Hopital Trousseau, Paris, France., Carausu L; CHRU Brest, Brest, France., Aladjidi N; Bordeaux University Hospital / CEREVANCE, BORDEAUX, France., Rigaud C; Gustave Roussy Cancer Campus, Villejuif, France., Leruste A; Institut Curie, Paris, France., Azarnoush S; Hôpital Robert Debré, AP-HP, Université de Paris, Paris, France, Paris, France., Lauvray T; Centre Hospitalo-Universitaire de Limoges, Limoges, France., Le Louet S; French Reference Center for Langerhans Cell Histiocytosis, Paris, France., Gandemer V; Department of Pediatric Hematology and Oncology CHU Hopital Sud, Rennes, France., Treguier P; Department of Pediatric Hematology and Oncology CHU Hopital Sud, Rennes, France., Mansuy L; Centre Hospitalo-Universitaire de Nancy, NANCY, France., Pasquet M; Hopital Purpan, CHU Toulouse, Toulouse, France., Olivier L; Hopital Purpan, CHU Toulouse, Toulouse, France., Rome A; La Timone University Hospital of Marseille, APHM, Marseille, France., Saultier P; La Timone University Hospital of Marseille, APHM, Department of Pediatric Oncology, Marseille, France., Isfan F; La Timone University Hospital of Marseille, APHM, Department of Pediatric Oncology, Marseille, France., Renard C; Institut d'hématologie et d'oncologie pédiatrique, Hospices Civils de Lyon, LYON, France., Li Thiao Te V; CHU AMIENS, Amiens, France., Salmon A; CHRU STRASBOURG, STRASBOURG, France., Blanc L; Centre Hospitalier Universitaire de Poitiers, Poitiers, France., Abou Chahla W; CHU de Lille, Hopital Jeanne De Flandre, Lille, France., Lambilliotte A; CHRU de Lille France, Lille, France., Stephan JL; University of Saint Etienne, Saint Etienne, France., Geissmann F; Memorial Sloan Kettering Cancer Center, NY, New York, United States., Lejeune J; Tours university hospital, Tours, France., Mallebranche C; Université d'Angers, Université de Nantes, Inserm, CNRS, CRCI2NA, SFR ICAT, Angers, France; CHU Angers, Pediatric immuno-hemato-oncology Unit, Angers, France, Angers, France., Reguerre Y; HOPITAL FELIX GUYON LA REUNION, saint denis, France., Grain A; Nantes University Hospital, Nantes, France., Thomas C; Nantes University Hospital, Nantes, France., Hélias-Rodzewicz Z; Nantes University Hospital, Nantes, France., Moshous D; Hôpital Necker-Enfants Malades, Paris, France., Fenneteau O; Hôpital Robert Debré APHP, PARIS, France., Coulomb-L'hermine A; Sorbonne Université - Trousseau Hospital, Paris, France., Lapillonne H; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, AP-HP Hôpital Trousseau, Paris, France, France., de Saint Basile G; Hopital Necker-Enfants Malades, Paris, France., Emile JF; Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France., Héritier S; French Reference Center for Langerhans Cell Histiocytosis, PARIS, France., Donadieu J; Hopital Trousseau, Paris, France.
Publikováno v:
Blood [Blood] 2024 Nov 01. Date of Electronic Publication: 2024 Nov 01.
Autor:
Dourthe ME; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris, France; Université Paris Cité, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, Paris. dourthe@aphp.fr., Auperin A; Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif., Rigaud C; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif., Barbati M; Department of Pediatric Oncology and Haematology, University Hospital of Lille, Lille., Bonneau J; Department of Pediatric Oncology and Haematology, University Hospital of Rennes, Rennes., Buchbinder N; Department of Pediatric Oncology and Haematology, University Hospital of Rouen, Rouen., Couec ML; Pediatric hematology and oncology department, University Hospital of Nantes, Nantes., Dartigues P; Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif., Ducassou S; Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux., Garnier N; Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon., Haouy S; Department of Pediatric Oncology and Haematology, University Hospital of Montpellier, Montpellier., Jonca B; Department of nuclear medicine, University Hospital Tenon, Paris., Jourdain A; Department of Pediatric Oncology and Haematology, University Hospital of Tours, Tours., Leruste A; SIREDO Oncology Center, Institut Curie, PSL Research University, Paris., Molina T; Department of biopathology, University Hospital Necker Enfants Malades, Université Paris Cité, Paris., Montravers F; Department of nuclear medicine, University Hospital Tenon, Paris., Pasquet M; Department of Pediatric Oncology and Haematology, University Hospital of Toulouse, Toulouse., Phulpin A; Pediatric Oncology and Hematology Department, University Hospital of Nancy (CHRU Nancy), Nancy., Poirée M; Department of Pediatric Oncology and Haematology, University Hospital of Nice, Nice., Simonin M; Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris., Spiegel A; Pediatric Hematology Oncology Department, University Hospital of Strasbourg, Strasbourg., Verschuur A; Department of Pediatric Hematology Immunology and Oncology, La Timone Hospital, APHM, Marseille., Leblanc T; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris., Landman-Parker J; Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris., Patte C; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif., Minard-Colin V; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM Unité 1015. veronique.minard@gustaveroussy.fr.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3790-3794. Date of Electronic Publication: 2024 Nov 01.
Autor:
Guerrini-Rousseau L; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. leaguerrini@hotmail.com.; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France. leaguerrini@hotmail.com., Gallon R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain., Brugières L; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Baert-Desurmont S; Inserm U1245, Univ Rouen Normandie, Rouen, France.; Department of Genetics, CHU Rouen, Rouen, France., Corsini C; Medical Genetics Department, Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France., Dangouloff-Ros V; Pediatric Radiology Department, Hôpital Necker Enfants Malades, AP-HP, Paris, France.; UMR 1163, Institut Imagine and INSERM U1299, Université Paris Cité, Paris, France., Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, The Netherlands., Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria., Hoarau P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Jongmans MC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Kloor M; Department of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, and Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center, Heidelberg, Germany., Loeffen J; Division of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Rigaud C; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Robbe J; Department of Genetics, Institut Curie, PSL University, Paris, France., Vibert R; Department of Genetics, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France., Weijers D; Division of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Colas C; Department of Genetics, Institut Curie, PSL University, Paris, France.
Publikováno v:
Familial cancer [Fam Cancer] 2024 Nov; Vol. 23 (4), pp. 447-457. Date of Electronic Publication: 2024 Jul 20.
Autor:
Rigaud C; Department of Children and Adolescents Oncology, Gustave Roussy Cancer, Paris-Saclay University, Villejuif, France., Forster VJ; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Al-Tarrah H; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Attarbaschi A; St Anna Children's Hospital, Medical University, Vienna, Austria.; St Anna Children's Cancer Research Institute, Vienna, Austria., Bianchi V; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Burke A; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, UK., Burkhardt B; NHL-BFM Study Center and Pediatric Hematology, Oncology and BMT, University Hospital Muenster, Muenster, Germany., Colas C; Department of Genetics, Institut Curie, University Paris Sciences Lettres, Paris, France., Devalck C; Hemato-Oncology Department, HUB, ULB, HUDERF, Brussels, Belgium., Edwards M; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Elitzur S; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Garthe AK; NHL-BFM Study Center and Pediatric Hematology, Oncology and BMT, University Hospital Muenster, Muenster, Germany., Goldberg Y; Raphael Recanati Genetics Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel.; Sackler School for Faculty, Tel Aviv University, Tel Aviv, Israel., Guerrini-Rousseau L; Department of Children and Adolescents Oncology, Gustave Roussy Cancer, Paris-Saclay University, Villejuif, France., Horpaopan S; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland., Kabíčková E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Kratz CP; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Loeffen J; Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Pérez-Alonso V; Pediatric Oncology Unit, University Hospital Doce de Octubre, Madrid, Spain., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), ONCOBELL Program, Barcelona, Spain.; Consortium for Biomedical Research in Cancer, CIBERONC, Carlos III Institute of Health, Madrid, Spain., Minard-Colin V; Department of Children and Adolescents Oncology, Gustave Roussy Cancer, Paris-Saclay University, Villejuif, France., Rueda D; Hereditary Cancer Genetic Diagnostic Laboratory, University Hospital Doce de Octubre, Madrid, Spain., Ruiz-Ponte C; Fundación Publica Galega de Medicina Xenómica, SERGAS, Grupo de Medicina Xenómica - Universidad de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago (IDIS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Santiago de Compostela, Spain., Trinquand A; National Children's Research Centre at Children's Health Ireland, Dublin, Ireland., Uyttebroeck A; Department of Oncology, KU Leuven, Pediatric Hemato-Oncology, University Hospitals Leuven, Herestraat 49, Leuven, Belgium., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Auperin A; Biostatistics and Epidemiology Departement, Gustave Roussy, Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France., Tabori U; Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada., Brugieres L; Department of Children and Adolescents Oncology, Gustave Roussy Cancer, Paris-Saclay University, Villejuif, France.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31302. Date of Electronic Publication: 2024 Sep 19.
Autor:
Bastard P; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France., Cozic N; Biostatistics Unit, Gustave Roussy, Villejuif, France., Brion R; Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (CRCI2NA), INSERM UMR 1307, CNRS UMR 6075, Université de NantesCHU de Nantes, Nantes, France., Gaspar N; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France.; INSERM U1015, University Paris-Saclay, Gustave Roussy, Villejuif, France., Piperno-Neumann S; Medical Oncology Department, Institut Curie, Paris, France., Cordero C; Pediatric Oncology Department, CHU-Hôpital de la Mère et de l'Enfant, Nantes, France., Leculée-Thébaud E; Pediatric Oncology Department, CHU-Hôpital de la Mère et de l'Enfant, Nantes, France., Gomez-Mascard A; Department of Pathology, CHU, IUCT-Oncopole, University of Toulouse, Eq19. ONCOSARC CRCT, UMR 1037 Inserm/UT3, ERL 5294 CNRS, Toulouse, France., Rédini F; Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (CRCI2NA), INSERM UMR 1307, CNRS UMR 6075, Université de NantesCHU de Nantes, Nantes, France., Marchais A; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France.; INSERM U1015, University Paris-Saclay, Gustave Roussy, Villejuif, France., Ikonomova R; Medical Oncology Department, Institut Curie, Paris, France., Cleirec M; Pediatric Oncology Department, CHU-Hôpital de la Mère et de l'Enfant, Nantes, France., Laurence V; Medical Oncology Department, Institut Curie, Paris, France., Rigaud C; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France., Abbas R; Biostatistics Unit, Gustave Roussy, Villejuif, France., Verrecchia F; Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (CRCI2NA), INSERM UMR 1307, CNRS UMR 6075, Université de NantesCHU de Nantes, Nantes, France., Brugières L; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France., Minard-Colin V; Department of Oncology for Child and Adolescents, University Paris-Saclay, Gustave Roussy, Villejuif, France.; INSERM U1015, University Paris-Saclay, Gustave Roussy, Villejuif, France.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jul; Vol. 71 (7), pp. e31029. Date of Electronic Publication: 2024 Apr 28.
Autor:
Huibers M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abla O; Division of Hematology and Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada., Andrés M; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain., Balagué O; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Carraro E; Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padova, Padova, Italy., Chiang A; Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong., Csóka M; Pediatric Clinic (Tűzoltó Street Department), Semmelweis University, Budapest, Hungary., David BA; Department of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Liège, Liège, Belgium., de Ville de Goyet M; Department of Pediatric Hematology and Oncology, Cliniques universitaires Saint-Luc, UC Louvain, Brussels, Belgium., Gilad G; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hori D; Department of Hematology and Oncology for children and adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan., Kotecha RS; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Australia.; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.; Curtin Medical School, Curtin University, Perth, Australia., Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Klapper W; Hematopathology Section, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany., Miakova N; Department of Pediatric Hematology and Oncology, Federal Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France., Nakazawa A; Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan., Pillon M; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Rigaud C; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France., Salaverria I; Department of Pathology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Tölle I; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany., Verdú-Amorós J; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.; Department of Pediatric Hematology and Oncology, Hospital Clínico Universitario, Biomedical Research Institute, INCLIVA, Valencia, Spain., von Mersi H; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Wössmann W; Pediatric Hematology and Oncology and NHL-BFM Study Center, Medical Center Hamburg-Eppendorf, Hamburg, Germany., Burkhardt B; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany., Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.
Publikováno v:
Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1509-1514.
Autor:
Lueza B; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Aupérin A; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Rigaud C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Gross TG; Department of Pediatrics, Center for Cancer and Blood Diseases, Children's Hospital Colorado, Aurora, CO, USA., Pillon M; Pediatric Hematology and Oncology, University of Padova, Padua, Italy., Delgado RF; Pediatric Hematology and Oncology, University of Valencia, Valencia, Spain., Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Louvain, Belgium., Amos Burke GA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Zsíros J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Csóka M; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary., Simonin M; Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital-APHP, Sorbonne University, Paris, France., Patte C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Minard-Colin V; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.; INSERM 1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Bonastre J; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France. julia.bonastre@gustaveroussy.fr.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France. julia.bonastre@gustaveroussy.fr.
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Mar; Vol. 25 (2), pp. 307-317. Date of Electronic Publication: 2023 Apr 14.
Autor:
Taipale, S. J., Rigaud, C., Calderini, M. L., Kainz, M. J., Pilecky, M., Uusi‐Heikkilä, S., Vesamäki, J. S., Vuorio, K., Tiirola, M.
Publikováno v:
Ecology Letters; Aug2023, Vol. 26 Issue 8, p1336-1347, 12p